Nuveen Asset Management, LLC Sorrento Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $539,744 - $1.33 Million	729,384 Added 34.67%	2,833,364 $2.51 Million
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $840,766 - $1.6 Million	556,799 Added 35.99%	2,103,980 $3.3 Million
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $647,911 - $1.22 Million	522,509 Added 50.99%	1,547,181 $3.11 Million
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $157,458 - $385,772	78,729 Added 8.32%	1,024,672 $2.57 Million
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $669,609 - $1.04 Million	-144,002 Reduced 13.21%	945,943 $5.66 Million

Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $932,192 - $1.38 Million	-125,802 Reduced 10.35%	1,089,945 $8.99 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $719,353 - $1.13 Million	113,284 Added 10.28%	1,215,747 $11.8 Million
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $1.22 Million - $2.87 Million	-173,671 Reduced 13.61%	1,102,463 $9.12 Million
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $347,414 - $720,764	60,315 Added 4.96%	1,276,134 $8.71 Million
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $2.41 Million - $7.34 Million	390,089 Added 47.24%	1,215,819 $13.6 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $540,095 - $2.11 Million	312,194 Added 60.79%	825,730 $5.19 Million
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $25,452 - $77,169	16,212 Added 3.26%	513,536 $944,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $65,052 - $187,082	-44,864 Reduced 8.27%	497,324 $1.68 Million
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.69 $191,568 - $251,375	93,448 Added 20.82%	542,188 $1.16 Million
Q2 2019 Aug 15, 2019	BUY	$2.67 - $4.38 $1.2 Million - $1.97 Million	448,740 New	448,740 $1.2 Million

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.51M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account